Assessing the Disease Burden Due to Epilepsy by Disability Adjusted Life Year in Rural China

Purpose: To demonstrate the application of Disability Adjusted Life Year (DALY) as an aid in health outcome measures to evaluate the epilepsy disease burden in rural China and to provide Chinese data to achieve a better understanding of disease burden due to epilepsy. Methods: The DALY is the sum of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Epilepsia (Copenhagen) 2006-12, Vol.47 (12), p.2032-2037
Hauptverfasser: Ding, Ding, Hong, Zhen, Wang, Wen‐zhi, Wu, Jian‐zhong, De Boer, Hanneke M., Prilipko, Leonid, Sander, Josemir W.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2037
container_issue 12
container_start_page 2032
container_title Epilepsia (Copenhagen)
container_volume 47
creator Ding, Ding
Hong, Zhen
Wang, Wen‐zhi
Wu, Jian‐zhong
De Boer, Hanneke M.
Prilipko, Leonid
Sander, Josemir W.
description Purpose: To demonstrate the application of Disability Adjusted Life Year (DALY) as an aid in health outcome measures to evaluate the epilepsy disease burden in rural China and to provide Chinese data to achieve a better understanding of disease burden due to epilepsy. Methods: The DALY is the sum of the number of years of survival with disability (Years Lived with Disability, YLD) and the number of years lost because of premature mortality (Years of Life Lost, YLL). We calculated the YLD based on the prevalence survey of epilepsy among 66,393 people sampled in Heilongjiang, Henan, Jiangsu, Ningxia, Shanghai, and Shanxi provinces in 2000. The epilepsy mortality data from Chinese literature provided the YLL due to epilepsy. We applied sensitivity analysis to evaluate the influence of uncertainty on the epilepsy mortality value and disability weight in the study. Results: In 2000, epilepsy caused 1.83 and 2.48 DALY lost per 1,000 population in Henan and Ningxia province, which had the lowest and the highest DALY lost among the six study areas. Overall, epilepsy caused 1.41 YLLs and 0.67 YLDs per 1,000 population; thus the DALYs lost because of epilepsy was 2.08 per 1,000 population, representing the epilepsy disease burden in rural China. Conclusions: The DALY measure, which includes the extent of disability from epilepsy, provides a useful tool for the epilepsy disease burden assessment. The disease burden of epilepsy in China is considered higher than previous estimations.
doi_str_mv 10.1111/j.1528-1167.2006.00802.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68284714</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68284714</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4772-4f669c29d24ad0c4fd258e4b244035f7de822a2b14b76cfcc7c68d9f757593523</originalsourceid><addsrcrecordid>eNqNkUFv1DAQhS0EotvCX0C-wC1h7DixI3FZtttSaSUQggMSkuXYY-pVNrvYidr8-ybsqj0WX2xpvvGbeY8QyiBn0_m4zVnJVcZYJXMOUOUACnh-_4IsHgsvyQKAFVldKjgj5yltAUBWsnhNzpjkwCTAgvxepoQphe4P7W-RXoaEJiH9PESHHb0ckPZ7uj6EFg9ppM04E6YJbehHunTbIfXo6CZ4pL_QRBo6-n2IpqWr29CZN-SVN23Ct6f7gvy8Wv9Yfck2X69vVstNZoWUPBO-qmrLa8eFcWCFd7xUKBouBBSllw4V54Y3TDSyst5aaSvlai9LWdZFyYsL8uH47yHu_w6Yer0LyWLbmg73Q9KV4kpIJp4FOdSTtJITqI6gjfuUInp9iGFn4qgZ6DkCvdWz03p2Ws8R6H8R6Pup9d1JY2h26J4aT55PwPsTYJI1rY-msyE9cUrwaa152E9H7m5yf_zvAfT62830KB4AHYSf4Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20925887</pqid></control><display><type>article</type><title>Assessing the Disease Burden Due to Epilepsy by Disability Adjusted Life Year in Rural China</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Wiley Free Content</source><source>IngentaConnect Free/Open Access Journals</source><source>Alma/SFX Local Collection</source><creator>Ding, Ding ; Hong, Zhen ; Wang, Wen‐zhi ; Wu, Jian‐zhong ; De Boer, Hanneke M. ; Prilipko, Leonid ; Sander, Josemir W.</creator><creatorcontrib>Ding, Ding ; Hong, Zhen ; Wang, Wen‐zhi ; Wu, Jian‐zhong ; De Boer, Hanneke M. ; Prilipko, Leonid ; Sander, Josemir W.</creatorcontrib><description>Purpose: To demonstrate the application of Disability Adjusted Life Year (DALY) as an aid in health outcome measures to evaluate the epilepsy disease burden in rural China and to provide Chinese data to achieve a better understanding of disease burden due to epilepsy. Methods: The DALY is the sum of the number of years of survival with disability (Years Lived with Disability, YLD) and the number of years lost because of premature mortality (Years of Life Lost, YLL). We calculated the YLD based on the prevalence survey of epilepsy among 66,393 people sampled in Heilongjiang, Henan, Jiangsu, Ningxia, Shanghai, and Shanxi provinces in 2000. The epilepsy mortality data from Chinese literature provided the YLL due to epilepsy. We applied sensitivity analysis to evaluate the influence of uncertainty on the epilepsy mortality value and disability weight in the study. Results: In 2000, epilepsy caused 1.83 and 2.48 DALY lost per 1,000 population in Henan and Ningxia province, which had the lowest and the highest DALY lost among the six study areas. Overall, epilepsy caused 1.41 YLLs and 0.67 YLDs per 1,000 population; thus the DALYs lost because of epilepsy was 2.08 per 1,000 population, representing the epilepsy disease burden in rural China. Conclusions: The DALY measure, which includes the extent of disability from epilepsy, provides a useful tool for the epilepsy disease burden assessment. The disease burden of epilepsy in China is considered higher than previous estimations.</description><identifier>ISSN: 0013-9580</identifier><identifier>EISSN: 1528-1167</identifier><identifier>DOI: 10.1111/j.1528-1167.2006.00802.x</identifier><identifier>PMID: 17201700</identifier><identifier>CODEN: EPILAK</identifier><language>eng</language><publisher>Malden, USA: Blackwell Publishing Inc</publisher><subject>Adolescent ; Adult ; Aged ; Anticonvulsants. Antiepileptics. Antiparkinson agents ; Biological and medical sciences ; Cause of Death ; Child ; Child, Preschool ; China - epidemiology ; Cost of Illness ; Disability Adjusted Life Year (DALY) ; Disability Evaluation ; Disease burden ; Epilepsy ; Epilepsy - diagnosis ; Epilepsy - epidemiology ; Epilepsy - mortality ; Female ; Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy ; Humans ; Male ; Medical sciences ; Metabolic diseases ; Metals (hemochromatosis...) ; Middle Aged ; Mortality ; Nervous system (semeiology, syndromes) ; Neurology ; Neuropharmacology ; Other metabolic disorders ; Outcome Assessment (Health Care) ; Pharmacology. Drug treatments ; Prevalence ; Quality-Adjusted Life Years ; Rural Population - statistics &amp; numerical data ; Survival Analysis</subject><ispartof>Epilepsia (Copenhagen), 2006-12, Vol.47 (12), p.2032-2037</ispartof><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4772-4f669c29d24ad0c4fd258e4b244035f7de822a2b14b76cfcc7c68d9f757593523</citedby><cites>FETCH-LOGICAL-c4772-4f669c29d24ad0c4fd258e4b244035f7de822a2b14b76cfcc7c68d9f757593523</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1528-1167.2006.00802.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1528-1167.2006.00802.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,1428,27905,27906,45555,45556,46390,46814</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18425934$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17201700$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ding, Ding</creatorcontrib><creatorcontrib>Hong, Zhen</creatorcontrib><creatorcontrib>Wang, Wen‐zhi</creatorcontrib><creatorcontrib>Wu, Jian‐zhong</creatorcontrib><creatorcontrib>De Boer, Hanneke M.</creatorcontrib><creatorcontrib>Prilipko, Leonid</creatorcontrib><creatorcontrib>Sander, Josemir W.</creatorcontrib><title>Assessing the Disease Burden Due to Epilepsy by Disability Adjusted Life Year in Rural China</title><title>Epilepsia (Copenhagen)</title><addtitle>Epilepsia</addtitle><description>Purpose: To demonstrate the application of Disability Adjusted Life Year (DALY) as an aid in health outcome measures to evaluate the epilepsy disease burden in rural China and to provide Chinese data to achieve a better understanding of disease burden due to epilepsy. Methods: The DALY is the sum of the number of years of survival with disability (Years Lived with Disability, YLD) and the number of years lost because of premature mortality (Years of Life Lost, YLL). We calculated the YLD based on the prevalence survey of epilepsy among 66,393 people sampled in Heilongjiang, Henan, Jiangsu, Ningxia, Shanghai, and Shanxi provinces in 2000. The epilepsy mortality data from Chinese literature provided the YLL due to epilepsy. We applied sensitivity analysis to evaluate the influence of uncertainty on the epilepsy mortality value and disability weight in the study. Results: In 2000, epilepsy caused 1.83 and 2.48 DALY lost per 1,000 population in Henan and Ningxia province, which had the lowest and the highest DALY lost among the six study areas. Overall, epilepsy caused 1.41 YLLs and 0.67 YLDs per 1,000 population; thus the DALYs lost because of epilepsy was 2.08 per 1,000 population, representing the epilepsy disease burden in rural China. Conclusions: The DALY measure, which includes the extent of disability from epilepsy, provides a useful tool for the epilepsy disease burden assessment. The disease burden of epilepsy in China is considered higher than previous estimations.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Anticonvulsants. Antiepileptics. Antiparkinson agents</subject><subject>Biological and medical sciences</subject><subject>Cause of Death</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>China - epidemiology</subject><subject>Cost of Illness</subject><subject>Disability Adjusted Life Year (DALY)</subject><subject>Disability Evaluation</subject><subject>Disease burden</subject><subject>Epilepsy</subject><subject>Epilepsy - diagnosis</subject><subject>Epilepsy - epidemiology</subject><subject>Epilepsy - mortality</subject><subject>Female</subject><subject>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Metabolic diseases</subject><subject>Metals (hemochromatosis...)</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Nervous system (semeiology, syndromes)</subject><subject>Neurology</subject><subject>Neuropharmacology</subject><subject>Other metabolic disorders</subject><subject>Outcome Assessment (Health Care)</subject><subject>Pharmacology. Drug treatments</subject><subject>Prevalence</subject><subject>Quality-Adjusted Life Years</subject><subject>Rural Population - statistics &amp; numerical data</subject><subject>Survival Analysis</subject><issn>0013-9580</issn><issn>1528-1167</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkUFv1DAQhS0EotvCX0C-wC1h7DixI3FZtttSaSUQggMSkuXYY-pVNrvYidr8-ybsqj0WX2xpvvGbeY8QyiBn0_m4zVnJVcZYJXMOUOUACnh-_4IsHgsvyQKAFVldKjgj5yltAUBWsnhNzpjkwCTAgvxepoQphe4P7W-RXoaEJiH9PESHHb0ckPZ7uj6EFg9ppM04E6YJbehHunTbIfXo6CZ4pL_QRBo6-n2IpqWr29CZN-SVN23Ct6f7gvy8Wv9Yfck2X69vVstNZoWUPBO-qmrLa8eFcWCFd7xUKBouBBSllw4V54Y3TDSyst5aaSvlai9LWdZFyYsL8uH47yHu_w6Yer0LyWLbmg73Q9KV4kpIJp4FOdSTtJITqI6gjfuUInp9iGFn4qgZ6DkCvdWz03p2Ws8R6H8R6Pup9d1JY2h26J4aT55PwPsTYJI1rY-msyE9cUrwaa152E9H7m5yf_zvAfT62830KB4AHYSf4Q</recordid><startdate>200612</startdate><enddate>200612</enddate><creator>Ding, Ding</creator><creator>Hong, Zhen</creator><creator>Wang, Wen‐zhi</creator><creator>Wu, Jian‐zhong</creator><creator>De Boer, Hanneke M.</creator><creator>Prilipko, Leonid</creator><creator>Sander, Josemir W.</creator><general>Blackwell Publishing Inc</general><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>200612</creationdate><title>Assessing the Disease Burden Due to Epilepsy by Disability Adjusted Life Year in Rural China</title><author>Ding, Ding ; Hong, Zhen ; Wang, Wen‐zhi ; Wu, Jian‐zhong ; De Boer, Hanneke M. ; Prilipko, Leonid ; Sander, Josemir W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4772-4f669c29d24ad0c4fd258e4b244035f7de822a2b14b76cfcc7c68d9f757593523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Anticonvulsants. Antiepileptics. Antiparkinson agents</topic><topic>Biological and medical sciences</topic><topic>Cause of Death</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>China - epidemiology</topic><topic>Cost of Illness</topic><topic>Disability Adjusted Life Year (DALY)</topic><topic>Disability Evaluation</topic><topic>Disease burden</topic><topic>Epilepsy</topic><topic>Epilepsy - diagnosis</topic><topic>Epilepsy - epidemiology</topic><topic>Epilepsy - mortality</topic><topic>Female</topic><topic>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Metabolic diseases</topic><topic>Metals (hemochromatosis...)</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Nervous system (semeiology, syndromes)</topic><topic>Neurology</topic><topic>Neuropharmacology</topic><topic>Other metabolic disorders</topic><topic>Outcome Assessment (Health Care)</topic><topic>Pharmacology. Drug treatments</topic><topic>Prevalence</topic><topic>Quality-Adjusted Life Years</topic><topic>Rural Population - statistics &amp; numerical data</topic><topic>Survival Analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ding, Ding</creatorcontrib><creatorcontrib>Hong, Zhen</creatorcontrib><creatorcontrib>Wang, Wen‐zhi</creatorcontrib><creatorcontrib>Wu, Jian‐zhong</creatorcontrib><creatorcontrib>De Boer, Hanneke M.</creatorcontrib><creatorcontrib>Prilipko, Leonid</creatorcontrib><creatorcontrib>Sander, Josemir W.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Epilepsia (Copenhagen)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ding, Ding</au><au>Hong, Zhen</au><au>Wang, Wen‐zhi</au><au>Wu, Jian‐zhong</au><au>De Boer, Hanneke M.</au><au>Prilipko, Leonid</au><au>Sander, Josemir W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Assessing the Disease Burden Due to Epilepsy by Disability Adjusted Life Year in Rural China</atitle><jtitle>Epilepsia (Copenhagen)</jtitle><addtitle>Epilepsia</addtitle><date>2006-12</date><risdate>2006</risdate><volume>47</volume><issue>12</issue><spage>2032</spage><epage>2037</epage><pages>2032-2037</pages><issn>0013-9580</issn><eissn>1528-1167</eissn><coden>EPILAK</coden><abstract>Purpose: To demonstrate the application of Disability Adjusted Life Year (DALY) as an aid in health outcome measures to evaluate the epilepsy disease burden in rural China and to provide Chinese data to achieve a better understanding of disease burden due to epilepsy. Methods: The DALY is the sum of the number of years of survival with disability (Years Lived with Disability, YLD) and the number of years lost because of premature mortality (Years of Life Lost, YLL). We calculated the YLD based on the prevalence survey of epilepsy among 66,393 people sampled in Heilongjiang, Henan, Jiangsu, Ningxia, Shanghai, and Shanxi provinces in 2000. The epilepsy mortality data from Chinese literature provided the YLL due to epilepsy. We applied sensitivity analysis to evaluate the influence of uncertainty on the epilepsy mortality value and disability weight in the study. Results: In 2000, epilepsy caused 1.83 and 2.48 DALY lost per 1,000 population in Henan and Ningxia province, which had the lowest and the highest DALY lost among the six study areas. Overall, epilepsy caused 1.41 YLLs and 0.67 YLDs per 1,000 population; thus the DALYs lost because of epilepsy was 2.08 per 1,000 population, representing the epilepsy disease burden in rural China. Conclusions: The DALY measure, which includes the extent of disability from epilepsy, provides a useful tool for the epilepsy disease burden assessment. The disease burden of epilepsy in China is considered higher than previous estimations.</abstract><cop>Malden, USA</cop><pub>Blackwell Publishing Inc</pub><pmid>17201700</pmid><doi>10.1111/j.1528-1167.2006.00802.x</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0013-9580
ispartof Epilepsia (Copenhagen), 2006-12, Vol.47 (12), p.2032-2037
issn 0013-9580
1528-1167
language eng
recordid cdi_proquest_miscellaneous_68284714
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Wiley Free Content; IngentaConnect Free/Open Access Journals; Alma/SFX Local Collection
subjects Adolescent
Adult
Aged
Anticonvulsants. Antiepileptics. Antiparkinson agents
Biological and medical sciences
Cause of Death
Child
Child, Preschool
China - epidemiology
Cost of Illness
Disability Adjusted Life Year (DALY)
Disability Evaluation
Disease burden
Epilepsy
Epilepsy - diagnosis
Epilepsy - epidemiology
Epilepsy - mortality
Female
Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy
Humans
Male
Medical sciences
Metabolic diseases
Metals (hemochromatosis...)
Middle Aged
Mortality
Nervous system (semeiology, syndromes)
Neurology
Neuropharmacology
Other metabolic disorders
Outcome Assessment (Health Care)
Pharmacology. Drug treatments
Prevalence
Quality-Adjusted Life Years
Rural Population - statistics & numerical data
Survival Analysis
title Assessing the Disease Burden Due to Epilepsy by Disability Adjusted Life Year in Rural China
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T15%3A50%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Assessing%20the%20Disease%20Burden%20Due%20to%20Epilepsy%20by%20Disability%20Adjusted%20Life%20Year%20in%20Rural%20China&rft.jtitle=Epilepsia%20(Copenhagen)&rft.au=Ding,%20Ding&rft.date=2006-12&rft.volume=47&rft.issue=12&rft.spage=2032&rft.epage=2037&rft.pages=2032-2037&rft.issn=0013-9580&rft.eissn=1528-1167&rft.coden=EPILAK&rft_id=info:doi/10.1111/j.1528-1167.2006.00802.x&rft_dat=%3Cproquest_cross%3E68284714%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20925887&rft_id=info:pmid/17201700&rfr_iscdi=true